4//SEC Filing
ELAN PHARMACEUTICAL INVESTMENTS LTD 4
Accession 0000950162-04-000744
CIK 0000810084other
Filed
Jun 16, 8:00 PM ET
Accepted
Jun 17, 4:42 PM ET
Size
9.9 KB
Accession
0000950162-04-000744
Insider Transaction Report
Form 4
ELAN CORP PLC
10% Owner
Transactions
- Sale
Common Stock
2004-06-15$1.96/sh−2,036,148$3,990,850→ 347,788 total(indirect: I)
Footnotes (1)
- [F1]The securities are beneficially owned indirectly by Elan Corporation, plc and by its wholly-owned subsidiary, Elan International Services, Ltd., and directly by Elan Pharmaceutical Investments, Ltd., a wholly-owned subsidiary of Elan International Services, Ltd.
Issuer
BIOJECT MEDICAL TECHNOLOGIES INC
CIK 0000810084
Entity typeother
Related Parties
1- filerCIK 0001279105
Filing Metadata
- Form type
- 4
- Filed
- Jun 16, 8:00 PM ET
- Accepted
- Jun 17, 4:42 PM ET
- Size
- 9.9 KB